Johan Maraganore is the founder of Alnylam Pharmaceuticals. Alnylam Pharmaceuticals has raised $135M in total funding. Latest round: Series A. Backed by Arch.
John Maraganore leads City Therapeutics, a startup that recently raised $135M in Series A funding. The company aims to advance RNAi technology. Arch led the funding round, with Robert Nelsen, managing director of Arch, stating that "The time to re-enter the RNAi revolution is now."
Full founder directory · Investor directory · Company funding database · Fundraising library